These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The use of antisense oligonucleotides for modulation of cytokine gene expression]. Kozlov VA; Sennikov SV Vopr Med Khim; 1997; 43(5):308-20. PubMed ID: 9446321 [TBL] [Abstract][Full Text] [Related]
3. Cytokines and therapeutic oligonucleotides. Hartmann G; Bidlingmaier M; Eigler A; Hacker U; Endres S Cytokines Cell Mol Ther; 1997 Dec; 3(4):247-56. PubMed ID: 9740353 [TBL] [Abstract][Full Text] [Related]
4. Not nonsense but antisense--applications of antisense oligonucleotides in different fields of medicine. Oberbauer R Wien Klin Wochenschr; 1997 Jan; 109(2):40-6. PubMed ID: 9123943 [TBL] [Abstract][Full Text] [Related]
5. A novel integrated strategy (full length gene targeting) for mRNA accessible site tagging combined with microarray hybridization/RNase H cleavage to screen effective antisense oligonucleotides. Sun Y; Duan M; Lin R; Wang D; Li C; Bo X; Wang S Mol Vis; 2006 Nov; 12():1364-71. PubMed ID: 17149362 [TBL] [Abstract][Full Text] [Related]
6. The effects of electroacupuncture on TH1/TH2 cytokine mRNA expression and mitogen-activated protein kinase signaling pathways in the splenic T cells of traumatized rats. Wang K; Wu H; Wang G; Li M; Zhang Z; Gu G Anesth Analg; 2009 Nov; 109(5):1666-73. PubMed ID: 19843806 [TBL] [Abstract][Full Text] [Related]
7. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration. Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM Transplantation; 2007 Mar; 83(6):764-73. PubMed ID: 17414711 [TBL] [Abstract][Full Text] [Related]
8. Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells. Aukunuru JV; Ayalasomayajula SP; Kompella UB J Pharm Pharmacol; 2003 Sep; 55(9):1199-206. PubMed ID: 14604462 [TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotides: from design to therapeutic application. Chan JH; Lim S; Wong WS Clin Exp Pharmacol Physiol; 2006; 33(5-6):533-40. PubMed ID: 16700890 [TBL] [Abstract][Full Text] [Related]
10. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications. Becker Y Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514 [TBL] [Abstract][Full Text] [Related]
12. Cytokine and cytokine receptor mRNA expression in human glioblastomas: evidence of Th1, Th2 and Th3 cytokine dysregulation. Hao C; Parney IF; Roa WH; Turner J; Petruk KC; Ramsay DA Acta Neuropathol; 2002 Feb; 103(2):171-8. PubMed ID: 11810184 [TBL] [Abstract][Full Text] [Related]
13. [The effects of nuclear factor-kappa B p65 antisense oligonucleotides on expression of proinflammatory cytokines in lamina propria mononuclear cells from patients with ulcerative colitis]. Gan H; Ouyang Q; Chen Y; Liang F Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):268-72. PubMed ID: 12856595 [TBL] [Abstract][Full Text] [Related]
15. Antisense oligonucleotides as therapeutics for malignant diseases. Ho PT; Parkinson DR Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689 [TBL] [Abstract][Full Text] [Related]
16. Effects of histamine on Th1/Th2 cytokine balance. Packard KA; Khan MM Int Immunopharmacol; 2003 Jul; 3(7):909-20. PubMed ID: 12810348 [TBL] [Abstract][Full Text] [Related]
17. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis. Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510 [TBL] [Abstract][Full Text] [Related]
18. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease. Gigi E; Raptopoulou-Gigi M; Kalogeridis A; Masiou S; Orphanou E; Vrettou E; Lalla TH; Sinakos E; Tsapas V J Viral Hepat; 2008 Feb; 15(2):145-54. PubMed ID: 18184198 [TBL] [Abstract][Full Text] [Related]
19. [Antisense oligonucleotides are clinically tested. They inhibit the expression of disease-related genes]. Sommer W; Heilig M Lakartidningen; 1999 Jan; 96(4):348-54. PubMed ID: 10024826 [TBL] [Abstract][Full Text] [Related]